Capitalizator.

Capitalize Yourself: Right Data. Real Growth.

Company Analysis

AGE Insider Trading

Serina Therapeutics, Inc. | Pharmaceutical Preparations

Comprehensive Trading Performance Summary

The investment history of corporate insiders at Serina Therapeutics, Inc. provides a unique lens into the internal conviction of the company's leadership. By analyzing SEC Form 4 filings, investors can track how directors and officers are allocating their own capital. High-conviction buying often signals that management believes the current market price significantly undervalues future growth prospects, while strategic selling might occur for personal liquidity or portfolio diversification. Monitoring these shifts in ownership is essential for understanding the alignment between management and shareholders in the Pharmaceutical Preparations sector.

Transactions on Chart

Open Full Chart
Filing Date Trade Date Reporting Person Relationship Type Price Qty Total, $ Owned After Change, %
2019-08-15 21:50 2019-08-13 Juvenescence Ltd 10% owner BUY $0.00 19,000 $0 16,419,000 +0.1%
2018-12-13 04:30 2018-12-10 WEST MICHAEL D Director, Officer - Chief Executive Officer BUY $3.86 4,000 $15,443 15,460 +34.9%
2007-07-06 22:01 2007-07-05 ATKIN MARY VERANTH Officer - Subsidiary Officer SELL $85.30 5,000 $426,500 63,692 -7.3%
2007-04-02 21:14 2007-03-29 ESCARRA VICKI B Director BUY $68.75 320 $22,000 5,493 +6.2%
2007-01-12 00:13 2006-12-27 ESCARRA VICKI B Director BUY $64.24 110 $7,066 5,173 +2.2%
2006-10-04 23:28 2006-10-03 CARTER EUGENE E Director SELL $54.56 10,000 $545,600 233,930 -4.1%
2006-09-22 23:36 2006-09-21 MARTIN THOMAS H JR Officer - Subsidiary Officer SELL $53.55 1,421 $76,095 7,229 -16.4%
2006-07-06 23:32 2006-07-06 CARTER EUGENE E Director SELL $54.90 5,000 $274,500 243,930 -2.0%
2006-07-06 21:08 2006-07-03 CARTER EUGENE E Director SELL $55.20 5,000 $276,000 248,930 -2.0%
2006-06-27 01:44 2006-06-22 PAUTLER PAUL F Officer - Subsidiary Officer SELL $51.89 6,000 $311,340 55,892 -9.7%
2006-06-27 01:30 2006-06-23 ESCARRA VICKI B Director BUY $53.10 94 $4,991 4,250 +2.3%
2006-06-14 02:40 2006-04-12 GOLDMAN ALFRED E Officer - Subsidiary Officer SELL $51.00 37 $1,887 42,664 -0.1%
2006-04-13 00:17 2006-04-11 CARTER EUGENE E Director SELL $51.50 5,000 $257,500 253,930 -1.9%
2006-04-12 23:57 2006-04-10 GOLDMAN ALFRED E Officer - subsidiary officer SELL $51.32 10,000 $513,200 36,466 -21.5%
2006-04-07 00:06 2006-04-04 CARTER EUGENE E Director SELL $49.45 5,000 $247,250 258,930 -1.9%
2006-04-03 23:03 2006-03-30 ESCARRA VICKI B Director BUY $48.09 510 $24,526 4,156 +14.0%
2006-01-10 23:30 2006-01-06 Diederich Gene M Officer - Executive VP SELL $46.60 5,061 $235,843 15,253 -24.9%
2006-01-10 23:40 2006-01-06 CARTER EUGENE E Director SELL $46.44 4,000 $185,760 263,930 -1.5%
2006-01-06 00:35 2006-01-03 Diederich Gene M Officer - Executive VP SELL $46.50 5,278 $245,427 20,314 -20.6%
2006-01-06 01:10 2006-01-03 CARTER EUGENE E Director SELL $46.26 6,000 $277,560 267,930 -2.2%
2005-12-30 00:35 2005-12-29 ATKIN MARY VERANTH Officer - subsidiary officer SELL $47.28 4,000 $189,120 39,555 -9.2%
2005-12-29 01:48 2005-12-23 MARTIN THOMAS H JR Officer - subsidiary officer SELL $46.72 500 $23,360 7,760 -6.1%
2005-12-27 23:50 2005-12-22 ESCARRA VICKI B Director BUY $46.04 139 $6,400 3,646 +4.0%
2005-10-06 19:25 2005-10-04 CARTER EUGENE E Director SELL $43.27 10,000 $432,720 273,930 -3.5%
2005-10-06 19:08 2005-10-05 MARTIN THOMAS H JR Officer - subsidiary officer SELL $43.12 500 $21,560 8,260 -5.7%
2005-09-27 00:03 2005-09-22 MARTIN THOMAS H JR Officer - subsidiary officer SELL $44.00 1,500 $66,000 8,643 -14.8%
2005-09-26 23:55 2005-09-22 ESCARRA VICKI B Director BUY $43.93 346 $15,200 3,507 +10.9%
2005-07-07 00:30 2005-07-01 CARTER EUGENE E Director SELL $45.62 17,180 $783,690 283,930 -5.7%
2005-06-30 00:40 2005-06-27 PORTER JOSEPH G Officer - Asst Corp Secretary SELL $43.54 5,000 $217,700 13,403 -27.2%
2005-06-30 00:58 2005-06-28 ESCARRA VICKI B Director BUY $42.86 139 $5,958 2,243 +6.6%
2005-04-14 23:32 2005-04-12 CARTER EUGENE E Director SELL $42.12 15,000 $631,850 301,110 -4.7%
2005-04-14 23:19 2005-04-13 MARTIN THOMAS H JR Officer - subsidiary officer SELL $41.88 752 $31,494 10,143 -6.9%
2005-04-05 20:29 2005-04-04 Diederich Gene M Officer - Executive VP SELL $43.30 5,825 $252,223 23,298 -20.0%
2005-04-05 20:09 2005-04-01 CARTER EUGENE E Director SELL $44.40 5,000 $222,000 316,110 -1.6%
2005-04-05 00:26 2005-03-31 GALLI CHARLES J Officer - subsidiary officer SELL $43.65 11,785 $514,415 84,596 -12.2%
2005-04-05 00:41 2005-04-04 ESCARRA VICKI B Director BUY $43.44 138 $5,995 2,104 +7.0%
2005-01-05 23:50 2005-01-03 CASEY DONNIS L Officer - subsidiary officer SELL $43.25 10,000 $432,500 23,725 -29.7%
2004-12-29 19:52 2004-12-27 CARTER EUGENE E Director SELL $42.86 5,000 $214,300 321,110 -1.5%
2004-12-28 22:45 2004-12-23 ESCARRA VICKI B Director BUY $41.60 127 $5,283 1,966 +6.9%
2004-12-28 00:18 2004-12-22 CASEY DONNIS L Officer - subsidiary officer SELL $41.43 20,000 $828,600 33,725 -37.2%
2004-10-09 00:01 2004-10-07 PARKER JOHN CHARLES II Officer - subsidiary officer BUY $29.54 647 $19,112 7,189 +9.9%
2004-10-08 22:25 2004-10-07 ATKIN MARY VERANTH Officer - subsidiary officer BUY $29.54 647 $19,112 41,995 +1.6%
2004-10-09 00:09 2004-10-07 PIETROBURGO ROBERT A Officer - Executive VP BUY $29.54 647 $19,112 20,764 +3.2%
2004-10-08 23:52 2004-10-07 MILLER PETER M Officer - Executive Officer BUY $29.54 647 $19,112 19,302 +3.5%
2004-10-09 00:05 2004-10-07 KESSLER RONALD J Officer - Vice Chairman BUY $29.54 647 $19,112 122,873 +0.5%
2004-10-08 23:25 2004-10-07 KELLY DOUGLAS L Officer - CFO & Corp. Secretary BUY $29.54 647 $19,112 45,730 +1.4%
2004-10-08 23:15 2004-10-07 GRABISH RICHARD F Officer - subsidiary officer BUY $29.54 647 $19,112 53,551 +1.2%
2004-10-08 22:56 2004-10-07 GALLI CHARLES J Officer - subsidiary officer BUY $29.54 647 $19,112 84,405 +0.8%
2004-10-08 22:42 2004-10-07 CASEY DONNIS L Officer - subsidiary officer BUY $29.54 647 $19,112 53,725 +1.2%
2004-09-28 00:03 2004-09-24 MARTIN THOMAS H JR Officer - subsidiary officer SELL $34.37 2,000 $68,740 10,172 -16.4%
SHOW ENTRIES

How to Interpret $AGE Trades

Not every insider transaction in Serina Therapeutics, Inc. is a signal for immediate action. Professional investors look for "cluster buying"—when multiple executives simultaneously purchase $AGE shares on the open market. It is crucial to distinguish between scheduled sales (under Rule 10b5-1) and voluntary increases in ownership, which demonstrate management’s true conviction that the stock is undervalued.

Data Source & Accuracy for AGE

Insider activity data for Serina Therapeutics, Inc. is streamed in real-time directly from the SEC EDGAR system. We analyze raw Form 4 filings, filtering out technical adjustments and complex derivative transactions. This provides a transparent view of how ownership structure is evolving in $AGE, allowing you to follow the capital of those with the most intimate knowledge of the company.

UNDERSTANDING THE DATA

FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.

TRADE DATE: The actual day the insider executed the purchase or sale in the market.

INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.

OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.

CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.

TRADE TYPES DEFINITIONS

BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.

SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.

OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.